
Auditor7 Sept 2026, 07:31 pm
Tavexia Lifecare Appoints DEVAM & Associates as New Auditor
AI Summary
Tavexia Lifecare Ltd announced the appointment of M/s DEVAM & Associates LLP as its new Statutory Auditors, replacing M/s SSRV & Associates who resigned. The appointment is subject to shareholder approval at the upcoming General Meeting and is for a term of five years. Additionally, the Board approved the re-appointment of Mrs. Khushboo Vasudev as an Independent Director for a second term and authorized preliminary evaluation for the acquisition of up to 60% equity in Meyonex Pharmaceuticals Limited.
Key Highlights
- New statutory auditor DEVAM & Associates LLP appointed.
- Appointment subject to shareholder approval at General Meeting.
- Independent Director re-appointed for a second five-year term.
- Board authorized preliminary evaluation for Meyonex Pharmaceuticals acquisition.
Price Impact
More from SATTVASUKU